Trading · Founded 1990 · www.indoeuroindchem.com · BSE 524458 · · ISIN INE319N01019
No Notes Added Yet
Business
Indo Euro Indchem Ltd. operates as a trading company in India. Given "Indchem" in its name, its core business likely involves the sourcing and distribution of industrial chemicals or related products. The company acts as an intermediary, purchasing goods from manufacturers (domestic or international) and selling them to various industrial end-users, thereby facilitating the supply chain for these products. Its business model revolves around generating profit margins from the difference between its procurement and selling prices, leveraging its network of suppliers and customers, as well as its logistical capabilities.
Revenue Mix
As a pure trading company, Indo Euro Indchem Ltd.'s primary segment is likely "Trading" itself. Without specific financial data, a detailed breakdown of revenue mix by product category (e.g., specific types of chemicals) or geographical region is not available. However, revenue would predominantly stem from the sale of traded industrial goods.
Industry
The trading industry in India, particularly for industrial chemicals, is generally fragmented and competitive. It includes numerous local distributors, agents, and larger players with diversified product portfolios. Companies in this space differentiate themselves through established relationships with suppliers and customers, efficient logistics, competitive pricing, and the ability to offer credit facilities. Without specific market share data, Indo Euro Indchem Ltd.'s positioning cannot be definitively stated relative to peers; however, it operates within this competitive landscape as an intermediary.
MOAT
Trading companies typically possess limited durable moats. Any competitive advantage for Indo Euro Indchem Ltd. would likely stem from:
Established Relationships: Long-standing trust and operational ties with key suppliers and customers.
Operational Efficiency: Effective supply chain management, warehousing, and distribution leading to cost advantages.
Market Knowledge: Deep understanding of product demand, pricing trends, and regulatory landscape within its specific chemical or industrial product niches.
Credit Facilities: Ability to offer competitive credit terms to customers and secure favorable terms from suppliers.
However, these advantages can often be replicated, making a strong, durable moat challenging to maintain in a pure trading business.
Growth Drivers
Key factors that could drive growth for Indo Euro Indchem Ltd. over the next 3-5 years include:
Industrial Growth in India: A robust manufacturing and industrial sector will directly increase demand for the chemicals and products it trades.
Product Portfolio Expansion: Adding new chemicals or industrial products to its trading basket to serve a broader customer base or new industries.
Geographical Expansion: Extending its distribution network to new regions within India or exploring export opportunities.
Deepening Customer Relationships: Increasing sales volume with existing clients through enhanced service or broader offerings.
Securing Exclusive Distribution Rights: Obtaining exclusive mandates for specific products from manufacturers, which can boost sales and margins.
Risks
Commodity Price Volatility: Fluctuations in the prices of industrial chemicals can impact margins and inventory values.
Intense Competition: The fragmented nature of the trading industry can lead to price wars and margin erosion.
Supply Chain Disruptions: Issues such as raw material shortages, logistical bottlenecks, or geopolitical events can affect product availability and delivery.
Credit Risk: Risk of default from customers, especially in an economically challenging environment.
Foreign Exchange Fluctuations: If the company imports chemicals, adverse movements in currency exchange rates can increase procurement costs.
Economic Downturn: A slowdown in industrial activity or general economic recession would directly reduce demand for traded goods.
Regulatory Changes: Changes in import/export policies, chemical handling regulations, or taxation could impact operations and costs.
Management & Ownership
Typical for many Indian companies, Indo Euro Indchem Ltd. is likely promoter-driven, with significant ownership and control residing with the founding family or individuals. Without specific details on the management team or ownership structure, a qualitative assessment of management quality or a detailed breakdown of shareholding patterns cannot be provided.
Outlook
The outlook for Indo Euro Indchem Ltd. is closely tied to the broader Indian industrial economy and its ability to effectively navigate the competitive trading landscape.
Bull Case: A strong and sustained growth trajectory in India's manufacturing and industrial sectors, coupled with the company's ability to forge strong supplier relationships, efficiently manage its supply chain, and expand its product portfolio, could lead to consistent revenue growth and stable margins. Its established network and market intelligence would be critical assets.
Bear Case: A significant slowdown in industrial demand, intense price competition from existing and new players, or major disruptions in its supply chain could put pressure on both revenue and profit margins. Inability to manage credit risk effectively or absorb commodity price volatility could also negatively impact profitability. The lack of a strong, defensible moat makes it susceptible to these external and operational pressures.
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 7 | 5 | 1 | 4 | 4 | 2 | 3 | 1 | 8 | 4 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income | 8 | 5 | 1 | 4 | 4 | 2 | 3 | 1 | 8 | 4 |
| Total Expenditure | 8 | 5 | 1 | 4 | 4 | 1 | 3 | 1 | 8 | 4 |
| Operating Profit | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 |
| Provision for Tax | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Tax | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 |
| Adjustments | 0 | 0 | -0 | 0 | -0 | 0 | 0 | 0 | 0 | -0 |
| Profit After Adjustments | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted Earnings Per Share | 0 | 0.2 | 0 | 0.2 | -0.1 | 0.2 | 0.1 | 0 | 0.1 | 0.1 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 3 | 6 | 3 | 8 | 1 | 6 | 8 | 23 | 10 | 11 | 14 | 16 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
| Total Income | 3 | 6 | 3 | 8 | 1 | 7 | 8 | 23 | 11 | 12 | 14 | 16 |
| Total Expenditure | 3 | 6 | 3 | 8 | 1 | 7 | 8 | 22 | 10 | 11 | 14 | 16 |
| Operating Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Tax | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Adjusted Earnings Per Share | 0.2 | -0.1 | 0.1 | 0.1 | 0.1 | 0 | 0.1 | 0.6 | 0.2 | 0 | 0.4 | 0.3 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 27% | -15% | 18% | 17% |
| Operating Profit CAGR | 0% | -100% | 0% | 0% |
| PAT CAGR | 0% | -100% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -35% | -9% | -4% | 2% |
| ROE Average | 3% | 2% | 2% | 1% |
| ROCE Average | 4% | 3% | 3% | 2% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 11 | 11 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| Total Current Liabilities | 1 | 0 | 0 | 4 | 1 | 6 | 7 | 6 | 5 | 6 | 8 |
| Total Liabilities | 11 | 11 | 11 | 14 | 11 | 16 | 17 | 17 | 16 | 17 | 20 |
| Fixed Assets | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 4 | 3 | 5 | 6 | 6 | 7 | 7 | 5 | 3 | 4 | 5 |
| Total Current Assets | 6 | 7 | 5 | 7 | 4 | 8 | 10 | 12 | 12 | 13 | 15 |
| Total Assets | 11 | 11 | 11 | 14 | 11 | 16 | 17 | 17 | 16 | 17 | 20 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash Flow from Operating Activities | -2 | -2 | 2 | 0 | 0 | 1 | -1 | -2 | -2 | 1 | 0 |
| Cash Flow from Investing Activities | 3 | 1 | 0 | 0 | 0 | -0 | 0 | 0 | 2 | -1 | -0 |
| Cash Flow from Financing Activities | -0 | -0 | -2 | -0 | -0 | -0 | 1 | 2 | -0 | -0 | -0 |
| Net Cash Inflow / Outflow | 1 | -1 | -0 | -0 | -0 | 0 | 0 | 0 | -0 | -0 | 0 |
| Closing Cash & Cash Equivalent | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 0.18 | -0.05 | 0.09 | 0.09 | 0.05 | 0.03 | 0.07 | 0.57 | 0.24 | 0.04 | 0.4 |
| CEPS(Rs) | 0.29 | 0.05 | 0.17 | 0.14 | 0.1 | 0.1 | 0.15 | 0.64 | 0.31 | 0.11 | 0.48 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 11.13 | 11.08 | 11.21 | 11.28 | 10.59 | 10.63 | 10.71 | 11.28 | 11.38 | 11.84 | 12.66 |
| Core EBITDA Margin(%) | 8.32 | -1.36 | -3.45 | -2.64 | -31.99 | -3.38 | -3.4 | 2.51 | -1.01 | -6 | -1.05 |
| EBIT Margin(%) | 6.8 | 0.93 | 3.16 | 1.92 | 9.12 | 0.83 | 1.39 | 3.26 | 3.17 | 1.79 | 2.88 |
| Pre Tax Margin(%) | 6.78 | 0.58 | 3.14 | 1.88 | 8.4 | 0.69 | 1.23 | 3.19 | 2.95 | 1.13 | 2.85 |
| PAT Margin (%) | 5.03 | -0.89 | 2.63 | 1.05 | 5.67 | 0.5 | 0.88 | 2.26 | 2.15 | 0.34 | 2.61 |
| Cash Profit Margin (%) | 8 | 0.85 | 5.05 | 1.67 | 11.54 | 1.47 | 1.76 | 2.55 | 2.8 | 0.91 | 3.1 |
| ROA(%) | 1.41 | -0.46 | 0.77 | 0.66 | 0.38 | 0.24 | 0.4 | 2.98 | 1.33 | 0.23 | 1.95 |
| ROE(%) | 1.63 | -0.49 | 0.81 | 0.79 | 0.47 | 0.33 | 0.7 | 5.15 | 2.12 | 0.35 | 3.27 |
| ROCE(%) | 2.02 | 0.5 | 0.97 | 1.44 | 0.75 | 0.55 | 1.09 | 7.37 | 3.11 | 1.85 | 3.62 |
| Receivable days | 244.7 | 254.52 | 464.94 | 206.27 | 1749.4 | 185.25 | 234.03 | 111.31 | 284.46 | 272.77 | 295.19 |
| Inventory Days | 136.83 | 109.9 | 161.75 | 56.19 | 506.98 | 124.6 | 168.78 | 56.49 | 89.9 | 85.29 | 56.51 |
| Payable days | 67.81 | 21.94 | 39.83 | 89.98 | 896.07 | 196.11 | 423.21 | 130.3 | 228.74 | 242.97 | 237.29 |
| PER(x) | 110.8 | 0 | 0 | 141.2 | 238.11 | 275.86 | 115.46 | 27.9 | 85.13 | 318.78 | 23.82 |
| Price/Book(x) | 1.79 | 0.72 | 0 | 1.11 | 1.14 | 0.9 | 0.8 | 1.4 | 1.8 | 1.1 | 0.75 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 5.33 | 1.25 | 2.85 | 1.46 | 13.49 | 1.38 | 1.01 | 0.62 | 1.83 | 1.08 | 0.61 |
| EV/Core EBITDA(x) | 54.56 | 47.12 | 51.18 | 57.61 | 90 | 76.01 | 44.57 | 17.34 | 47.87 | 45.98 | 18.13 |
| Net Sales Growth(%) | 56.04 | 71.36 | -44.18 | 147.9 | -89.4 | 681.43 | 20.12 | 197.49 | -55.46 | 7.3 | 28.33 |
| EBIT Growth(%) | 99.47 | -76.68 | 90.48 | 50.49 | -49.58 | -28.73 | 101.16 | 595.66 | -56.69 | -39.23 | 106.34 |
| PAT Growth(%) | 66.12 | -130.26 | 265.58 | -1.55 | -42.54 | -31.74 | 114 | 661.31 | -57.6 | -82.94 | 879.19 |
| EPS Growth(%) | 66.09 | -130.29 | 265.44 | -1.56 | -42.55 | -31.63 | 113.79 | 661.16 | -57.6 | -82.92 | 878.05 |
| Debt/Equity(x) | 0.04 | 0 | 0 | 0 | 0 | 0.01 | 0.01 | 0.01 | 0 | 0 | 0 |
| Current Ratio(x) | 7.23 | 14.44 | 12.9 | 1.96 | 3.94 | 1.33 | 1.32 | 1.9 | 2.61 | 2.26 | 1.88 |
| Quick Ratio(x) | 5.22 | 10.89 | 9.86 | 1.61 | 2.88 | 0.78 | 0.81 | 1.37 | 2.26 | 1.65 | 1.77 |
| Interest Cover(x) | 355.48 | 2.65 | 252.45 | 56.41 | 12.77 | 6.04 | 8.62 | 47.88 | 14.26 | 2.71 | 95.36 |
| Total Debt/Mcap(x) | 0.02 | 0 | 0 | 0 | 0 | 0.01 | 0.01 | 0 | 0 | 0 | 0 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 56.21 | 56.21 | 56.21 | 56.21 | 56.21 | 56.24 | 56.24 | 56.24 | 56.24 | 56.24 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.59 | 0.59 | 0.59 | 0.59 | 0.59 | 0.59 | 0.59 | 0.59 | 0.59 | 0.59 |
| Public | 43.19 | 43.19 | 43.19 | 43.19 | 43.19 | 43.17 | 43.17 | 43.17 | 43.17 | 43.17 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Public | 0.39 | 0.39 | 0.39 | 0.39 | 0.39 | 0.39 | 0.39 | 0.39 | 0.39 | 0.39 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.91 | 0.91 | 0.91 | 0.91 | 0.91 | 0.91 | 0.91 | 0.91 | 0.91 | 0.91 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +27% | -15% | +18% | +17% |
| Operating Profit CAGR | — | -100% | — | — |
| PAT CAGR | — | -100% | — | — |
| Share Price CAGR | -35% | -9% | -4% | +2% |
| ROE Average | +3% | +2% | +2% | +1% |
| ROCE Average | +4% | +3% | +3% | +2% |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 56.21 | 56.21 | 56.21 | 56.21 | 56.21 | 56.24 | 56.24 | 56.24 | 56.24 | 56.24 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.59 | 0.59 | 0.59 | 0.59 | 0.59 | 0.59 | 0.59 | 0.59 | 0.59 | 0.59 |
| Public | 43.19 | 43.19 | 43.19 | 43.19 | 43.19 | 43.17 | 43.17 | 43.17 | 43.17 | 43.17 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Public | 0.39 | 0.39 | 0.39 | 0.39 | 0.39 | 0.39 | 0.39 | 0.39 | 0.39 | 0.39 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.91 | 0.91 | 0.91 | 0.91 | 0.91 | 0.91 | 0.91 | 0.91 | 0.91 | 0.91 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.